Article Information
History
- May 10, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sixten Körper1,
- Manfred Weiss2,
- Daniel Zickler3,
- Thomas Wiesmann4,
- Kai Zacharowski5,
- Victor M.Corman6,
- Beate Grüner7,
- Lucas Ernst3,
- Peter Spieth8,
- Philipp M. Lepper9,
- Martin Bentz10,
- Sebastian Zinn5,
- Gregor Paul11,
- Johannes Kalbhenn12,
- Matthias Dollinger13,
- Peter Rosenberger14,
- Thomas Kirschning15,
- Thomas Thiele16,
- Thomas Appl1,
- Benjamin Mayer17,
- Michael Schmidt18,
- Christian Drosten6,
- Hinnerk Wulf4,
- Jan Matthias Kruse3,
- Bettina Jungwirth2,
- Erhard Seifried18,
- Hubert Schrezenmeier1,#,
- for the CAPSID Clinical Trial Group§
- 1Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm and Institute of Transfusion Medicine, University of Ulm
- 2Department of Anaesthesiology and Intensive Care Medicine, University Hospital Ulm, Ulm University, Ulm, Germany
- 3Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Free University Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
- 4Department of Anaesthesiology and Intensive Care Medicine, Phillips-University Marburg, Marburg, Germany
- 5Clinic of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt, Germany
- 6Institute of Virology, Charité- University Medicine Berlin, corporate member of Free University Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health and German Centre for Infection Research, Berlin, Germany
- 7Division of Infectious Diseases, University Hospital and Medical Center Ulm, Ulm, Germany
- 8Department of Anesthesiology and Critical Care Medicine, Carl Gustav Carus University Hospital, Technische Universität Dresden, Dresden, Germany
- 9Department of Internal Medicine V – Pneumology, Allergology, Intensive Care Medicine, Saarland University Hospital, Homburg, Germany
- 10Department of Internal Medicine III, Hospital of Karlsruhe, Karlsruhe, Germany
- 11Department of Gastroenterology, Hepatology, Pneumology and Infectious Diseases, Klinikum Stuttgart, Stuttgart, Germany
- 12Clinic of Anesthesiology and Intensive Care Medicine University Medical Center of Freiburg, Germany
- 13Medical Clinic I, Klinikum Landshut, Landshut, Germany
- 14Department of Anesthesiology and Intensive Care Medicine, University Hospital Tübingen, Tübingen, Germany
- 15Clinic for Anesthesiology and Surgical Intensive Care Medicine, University of Mannheim, Mannheim, Germany
- 16Institute of Immunology and Transfusion Medicine, University Hospital Greifswald, Greifswald, Germany
- 17Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany
- 18Institute of Transfusion Medicine and Immunohematology, German Red Cross Blood Transfusion Service Baden-Württemberg – Hessen, Frankfurt, Germany
- ↵#Correspondence: Univ-Prof.Dr.med.Hubert Schrezenmeier, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm and Institute of Transfusion Medicine, University of Ulm. h.schrezenmeier{at}blutspende.de
Contributions: HS and SK: Wrote study protocol, coordinated the study, analyzed and interpreted data, wrote the manuscript. HS, SK and ES applied for funding.
HS and ES: Lead Investigators
MW, DZ, TW, KZ, BG, LE, PS, PML, MB, SZ, GP, JK, MD, PR, TK, TT, HW, JMK, BJ: patient care, data collection
VMC, CD: analysis of SARS-CoV-2 antibodies
MS: SARS-CoV-2 PCR
TA: project management
BM: performed statistical analysis
MS: SARS-CoV-2-PCR
All authors have approved the manuscript
Posted May 10, 2021.
High Dose Convalescent Plasma in COVID-19: Results from the Randomized Trial CAPSID
